2. Academic Validation
  3. Potent inhibitors of protein farnesyltransferase: heteroarenes as cysteine replacements

Potent inhibitors of protein farnesyltransferase: heteroarenes as cysteine replacements

  • Bioorg Med Chem Lett. 1999 Mar 8;9(5):703-8. doi: 10.1016/s0960-894x(99)00080-3.
W Shen 1,  S Fakhoury,  G Donner,  K Henry,  J Lee,  H Zhang,  J Cohen,  R Warner,  B Saeed,  S Cherian,  S Tahir,  P Kovar,  J Bauch,  S C Ng,  K Marsh,  H Sham,  S Rosenberg
Affiliations

Affiliation

  • 1 Cancer Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, IL 60064, USA.
PMID: 10201832 DOI: 10.1016/s0960-894x(99)00080-3
Abstract

Synthesis and biological evaluation of heteroarenes as reduced cysteine replacements are described. Of the heteroaryl groups examined with respect to FT inhibitor FTI-276 (1), pyridyl was the replacement found to be most effective. Substitutions at C4 of the pyridyl moiety did not affect the in vitro activity. Compound 9a was found to have moderate in vivo bioavailability.

Figures